Cargando…
Severe epistaxis related to intravitreal bevacizumab
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004067/ https://www.ncbi.nlm.nih.gov/pubmed/31233274 http://dx.doi.org/10.1111/aos.14176 |
| _version_ | 1783494654089494528 |
|---|---|
| author | Otten, Leila S. Butterhoff‐Terlingen, Madelon H. Mulder, Verena C. Lagas‐ de Graaf, Willemien van der Hage‐Lie, Angela M. van der Linden, Paul D. |
| author_facet | Otten, Leila S. Butterhoff‐Terlingen, Madelon H. Mulder, Verena C. Lagas‐ de Graaf, Willemien van der Hage‐Lie, Angela M. van der Linden, Paul D. |
| author_sort | Otten, Leila S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7004067 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70040672020-02-11 Severe epistaxis related to intravitreal bevacizumab Otten, Leila S. Butterhoff‐Terlingen, Madelon H. Mulder, Verena C. Lagas‐ de Graaf, Willemien van der Hage‐Lie, Angela M. van der Linden, Paul D. Acta Ophthalmol Letters to the Editor John Wiley and Sons Inc. 2019-06-24 2020-02 /pmc/articles/PMC7004067/ /pubmed/31233274 http://dx.doi.org/10.1111/aos.14176 Text en © 2019 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters to the Editor Otten, Leila S. Butterhoff‐Terlingen, Madelon H. Mulder, Verena C. Lagas‐ de Graaf, Willemien van der Hage‐Lie, Angela M. van der Linden, Paul D. Severe epistaxis related to intravitreal bevacizumab |
| title | Severe epistaxis related to intravitreal bevacizumab |
| title_full | Severe epistaxis related to intravitreal bevacizumab |
| title_fullStr | Severe epistaxis related to intravitreal bevacizumab |
| title_full_unstemmed | Severe epistaxis related to intravitreal bevacizumab |
| title_short | Severe epistaxis related to intravitreal bevacizumab |
| title_sort | severe epistaxis related to intravitreal bevacizumab |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004067/ https://www.ncbi.nlm.nih.gov/pubmed/31233274 http://dx.doi.org/10.1111/aos.14176 |
| work_keys_str_mv | AT ottenleilas severeepistaxisrelatedtointravitrealbevacizumab AT butterhoffterlingenmadelonh severeepistaxisrelatedtointravitrealbevacizumab AT mulderverenac severeepistaxisrelatedtointravitrealbevacizumab AT lagasdegraafwillemien severeepistaxisrelatedtointravitrealbevacizumab AT vanderhagelieangelam severeepistaxisrelatedtointravitrealbevacizumab AT vanderlindenpauld severeepistaxisrelatedtointravitrealbevacizumab |